Clinical Genomics Revenue and Competitors
Estimated Revenue & Valuation
- Clinical Genomics's estimated annual revenue is currently $3.9M per year.
- Clinical Genomics's estimated revenue per employee is $77,500
- Clinical Genomics's total funding is $19.7M.
Employee Data
- Clinical Genomics has 50 Employees.
- Clinical Genomics grew their employee count by 0% last year.
Clinical Genomics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | VP Science & Innovation/CSO/Co-Founder | Reveal Email/Phone |
2 | CSO | Reveal Email/Phone |
3 | VP Sales and Marketing | Reveal Email/Phone |
4 | VP Regulatory Affairs | Reveal Email/Phone |
5 | Chief Financial Officer | Reveal Email/Phone |
6 | Chief Medical Officer | Reveal Email/Phone |
7 | Channel Manager | Reveal Email/Phone |
8 | Global Legal Operations Manager, Chair Compliance Committee & Patent Committee | Reveal Email/Phone |
9 | Client Experience Representative | Reveal Email/Phone |
10 | Chairman | Reveal Email/Phone |
Clinical Genomics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $8.5M | 55 | -21% | N/A | N/A |
#2 | $0.2M | 1 | 0% | N/A | N/A |
#3 | $8.5M | 55 | -29% | N/A | N/A |
#4 | $108.5M | 500 | 2% | N/A | N/A |
#5 | $0.8M | 5 | 0% | N/A | N/A |
#6 | $0.6M | 4 | 0% | N/A | N/A |
#7 | $14.7M | 68 | -23% | $206.4M | N/A |
#8 | $492.2M | 1503 | -15% | $568M | N/A |
#9 | $1.1M | 7 | -42% | N/A | N/A |
#10 | $4.5M | 29 | 0% | N/A | N/A |
What Is Clinical Genomics?
Clinical Genomics is a privately held biotechnology company developing innovative products for colorectal cancer diagnosis and monitoring. With a broad intellectual property portfolio including more than 20 issued and pending patents, Clinical Genomics has developed and validated a sensitive and specific blood test for colorectal cancer recurrence monitoring that will be launched in the U.S. in 2016. This 2-gene test, which is based on methylated DNA from two genes, BCAT1 and IKZF1, is currently known by its project name GEMINI.
keywords:N/A
$19.7M
Total Funding
50
Number of Employees
$3.9M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Clinical Genomics News
Currently, the human reference genome is based primarily on sequencing data ... an increasing demand for and interest in clinical genomics,...
NGS Informatics and Clinical Genomics Market Size, Outlook And Forecast | 2bPrecise, Epic Systems, Flatiron Health, GenomOncology, Illumina, IBM, Koninklijke...
Comprehensive genome annotation is essential to understand the impact of clinically relevant variants. However, the absence of a standard...
Clinical Genomics, a biotechnology company working across the United States and Australia, has closed a US$15 million ($19.7 million) round led by Sydney-based VC firm OneVentures. Dr Paul Kelly, partner at and managing director of OneVentures and former CEO of biotech company Gemini Genomics, w ...
Clinical Genomics, a Edison, N.J.-based developer of diagnostic tools for colorectal cancer, closed a $15m Series A financing round. The round was led by OneVentures, a venture capital firm headquartered in Sydney, Australia that provides human and investment capital into high growth technology ...
Other Companies in Bridgewater
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $11.6M | 50 | 6% | N/A |
#2 | $12.9M | 53 | 6% | N/A |
#3 | $7.5M | 54 | 10% | N/A |
#4 | $5.1M | 57 | 0% | N/A |
#5 | $14.1M | 58 | 0% | N/A |